Skip to main content
. Author manuscript; available in PMC: 2014 Jul 15.
Published in final edited form as: Clin Cancer Res. 2013 May 29;19(14):3764–3775. doi: 10.1158/1078-0432.CCR-12-3725

Figure 1.

Figure 1

Modulation of S100B production does not affect proliferation of GL261 glioma cells in vitro. Cells were stably transected with plasmids that carried either S100B siRNA or cDNA to knockdown (S100Blow) or enhance (S100Bhigh) S100B expression, respectively. Cells transfected with bank plasmid (S100Bwt) were used as control. S100B production by each cell line was measured by A, Western blot and B, ELISA. In vitro proliferate rates of S100Blow and S100Bhigh cells were similar to control cells as measured by C, cell number/plate or, D, BrdU uptake. Experimental results are representative of at least two separate experiments (n=3, ±SD). * : p < 0.05.